{"id":43170,"date":"2025-07-09T11:53:13","date_gmt":"2025-07-09T06:23:13","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=43170"},"modified":"2025-07-09T11:57:53","modified_gmt":"2025-07-09T06:27:53","slug":"asston-pharmaceuticals-ipo","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/asston-pharmaceuticals-ipo\/","title":{"rendered":"Asston Pharmaceuticals IPO GMP: Day 1 IPO Live Updates"},"content":{"rendered":"<p><strong>Asston Pharmaceuticals IPO GMP <\/strong>is \u20b910 as of 9th July 2025. It is a book building IPO of 22.41 lakh shares and entirely a fresh issue worth \u20b927.56 crore. The issue will be listed on BSE and SME on its tentative listing date, 16th July 2025. The price band for the <strong>Asston Pharmaceuticals IPO <\/strong>is set between \u20b9115 and \u20b9123 per share. Retail investors can bid for a minimum 2 lots of 2,000 shares worth \u20b92,46,000.&nbsp;<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/asston-pharmaceuticals-ipo\/#Asston_Pharmaceuticals_IPO_GMP_Grey_Market_Premium\" title=\"Asston Pharmaceuticals IPO GMP Grey Market Premium\">Asston Pharmaceuticals IPO GMP Grey Market Premium<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/asston-pharmaceuticals-ipo\/#Asston_Pharmaceuticals_IPO_Details\" title=\"Asston Pharmaceuticals IPO Details\">Asston Pharmaceuticals IPO Details<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/asston-pharmaceuticals-ipo\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/asston-pharmaceuticals-ipo\/#Objectives_of_Asston_Pharmaceuticals_IPO\" title=\"Objectives of Asston Pharmaceuticals IPO\">Objectives of Asston Pharmaceuticals IPO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/asston-pharmaceuticals-ipo\/#Asston_Pharmaceuticals_IPO_Registrar\" title=\"Asston Pharmaceuticals IPO Registrar\">Asston Pharmaceuticals IPO Registrar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/asston-pharmaceuticals-ipo\/#Asston_Pharmaceuticals_IPO_Review\" title=\"Asston Pharmaceuticals IPO Review\">Asston Pharmaceuticals IPO Review<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/asston-pharmaceuticals-ipo\/#Asston_Pharmaceuticals_Limited_Peer_Comparison\" title=\"Asston Pharmaceuticals Limited Peer Comparison\">Asston Pharmaceuticals Limited Peer Comparison<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/asston-pharmaceuticals-ipo\/#FAQs_on_Asston_Pharmaceuticals_IPO\" title=\"FAQs on Asston Pharmaceuticals IPO\">FAQs on Asston Pharmaceuticals IPO<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/asston-pharmaceuticals-ipo\/#What_is_Asston_Pharmaceuticals_IPO_GMP\" title=\"What is Asston Pharmaceuticals IPO GMP?\">What is Asston Pharmaceuticals IPO GMP?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/asston-pharmaceuticals-ipo\/#What_is_the_issue_price_of_Asston_Pharmaceuticals_IPO\" title=\"What is the issue price of Asston Pharmaceuticals IPO?\">What is the issue price of Asston Pharmaceuticals IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/asston-pharmaceuticals-ipo\/#Who_is_the_registrar_of_the_Asston_Pharmaceuticals_IPO\" title=\"Who is the registrar of the Asston Pharmaceuticals IPO?\">Who is the registrar of the Asston Pharmaceuticals IPO?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/asston-pharmaceuticals-ipo\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Asston_Pharmaceuticals_IPO_GMP_Grey_Market_Premium\"><\/span><strong>Asston Pharmaceuticals IPO GMP Grey Market Premium<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>As of 9th July 2025, <strong>Asston Pharmaceuticals IPO GMP <\/strong>stands at \u20b910 per share. Thus, the estimated listing price would be \u20b9133 (123+10). This indicates that the estimated listing gain in this IPO could be 8.13%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the <strong>Asston Pharmaceuticals IPO<\/strong> GMP updates.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>GMP Date<\/strong><\/td><td><strong>IPO Price<\/strong><\/td><td><strong>GMP<\/strong><\/td><td><strong>Estimated Listing Price&nbsp;<\/strong><\/td><td><strong>Estimated Listing Gains<\/strong><\/td><\/tr><tr><td><strong>09-07-2025<\/strong><\/td><td>\u20b9123<\/td><td>\u20b910<\/td><td>\u20b9133<\/td><td>8.13%<\/td><\/tr><tr><td><strong>08-07-2025<\/strong><\/td><td>\u20b9123<\/td><td>\u20b910<\/td><td>\u20b9133<\/td><td>8.13%<\/td><\/tr><tr><td><strong>07-07-2025<\/strong><\/td><td>\u20b9123<\/td><td>\u20b910<\/td><td>\u20b9133<\/td><td>8.13%<\/td><\/tr><tr><td><strong>06-07-2025<\/strong><\/td><td>\u20b9123<\/td><td>\u20b910<\/td><td>\u20b9133<\/td><td>8.13%<\/td><\/tr><tr><td><strong>05-07-2025<\/strong><\/td><td>\u20b9123<\/td><td>\u20b910<\/td><td>\u20b9133<\/td><td>8.13%<\/td><\/tr><tr><td><strong>04-07-2025<\/strong><\/td><td>\u20b9123<\/td><td>\u20b90<\/td><td>\u20b9123<\/td><td>0.00%<\/td><\/tr><tr><td><strong>03-07-2025<\/strong><\/td><td>\u20b9123<\/td><td>\u20b90<\/td><td>\u20b9123<\/td><td>0.00%<\/td><\/tr><tr><td><strong>02-07-2025<\/strong><\/td><td>\u20b9123<\/td><td>\u20b90<\/td><td>\u20b9123<\/td><td>0.00%<\/td><\/tr><tr><td><strong>01-07-2025<\/strong><\/td><td>\u20b9123<\/td><td>\u20b90<\/td><td>\u20b9123<\/td><td>0.00%<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Asston_Pharmaceuticals_IPO_Details\"><\/span><strong>Asston Pharmaceuticals IPO Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Open Date<\/strong><\/td><td>9th July 2025<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>11th July 2025<\/td><\/tr><tr><td><strong>IPO Allotment Date<\/strong><\/td><td>14th July 2025<\/td><\/tr><tr><td><strong>Refund Initiation&nbsp;<\/strong><\/td><td>15th July 2025<\/td><\/tr><tr><td><strong>Issue Size<\/strong><\/td><td>22,41,000 shares (worth \u20b927.56 crore)<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>1,000 shares<\/td><\/tr><tr><td><strong>Issue Price Band<\/strong><\/td><td>\u20b9115 to \u20b9123 per share<\/td><\/tr><tr><td><strong>Issue Type<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>BSE &amp; SME<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>16th July 2025<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p><strong>Asston Pharmaceuticals IPO<\/strong>: Asston Pharmaceuticals Limited has declared a price band of \u20b9115 and \u20b9124 per share. With this IPO, the company allows retail investors to bid for at least 2 lots of 2,000 shares worth \u20b92,46,000. The face value of Asston Pharmaceuticals Ltd.&#8217;s share is \u20b910 per share. The shares of Asston Pharmaceuticals Limited will be listed on BSE &amp; SME on its tentative listing day, 16th July 2025. Scroll down to check GMP updates and <strong>Asston Pharmaceuticals IPO<\/strong> reviews.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Objectives_of_Asston_Pharmaceuticals_IPO\"><\/span><strong>Objectives of Asston Pharmaceuticals IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The primary aim of the <strong>Asston Pharmaceuticals IPO<\/strong> is to raise \u20b927.56 crores. On the other hand, Asston Pharmaceuticals Limited has decided to utilise these funds in different prospects. Explore some of the secondary objectives for the Asston Pharmaceuticals IPO.<\/p><ul class=\"wp-block-list\"><li>To meet capital expenditure on the acquisition of machinery in the manufacturing facility.<\/li>\n\n<li>To meet the general corporate purposes.<\/li>\n\n<li>To fund the incremental working capital requirements of the company.<\/li>\n\n<li>To repay certain borrowings.&nbsp;<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Asston_Pharmaceuticals_IPO_Registrar\"><\/span><strong>Asston Pharmaceuticals IPO Registrar<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Maashitla Securities Private Limited is the registrar of the <strong>Asston Pharmaceuticals IPO,<\/strong> awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding the <strong>Asston Pharmaceuticals IPO<\/strong> allotment and refund, you can contact Maashitla Securities Private Limited at <a href=\"mailto:investor.ipo@maashitla.com\">investor.ipo@maashitla.com<\/a> or +91-11-45121795-96.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Asston_Pharmaceuticals_IPO_Review\"><\/span><strong>Asston Pharmaceuticals IPO Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/07\/09115023\/asston-image-2-08-1024x536.jpg\" alt=\"\" class=\"wp-image-43185\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/07\/09115023\/asston-image-2-08-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/07\/09115023\/asston-image-2-08-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/07\/09115023\/asston-image-2-08-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/07\/09115023\/asston-image-2-08-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/07\/09115023\/asston-image-2-08-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/07\/09115023\/asston-image-2-08-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/07\/09115023\/asston-image-2-08.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>The <strong>Asston Pharmaceuticals IPO<\/strong> has gained neutral ratings from industry experts, brokers, and institutional investors. Asston Pharmaceuticals Limited&#8217;s revenue soared by 61.67% from \u20b915.84 crores in March 2024 to \u20b925.61 crores in March 2025. Moreover, the company&#8217;s PAT increased by 218.38% from \u20b91.36 crores to \u20b94.33 crores. Investors can analyse other relevant factors and make a decision accordingly.<\/p><p>Most analysts recommend applying for this IPO to diversify your investment portfolio in the stock market. However, we\u2019re waiting for further ratings to have a better idea and will keep posting them to deliver real-time insights. Until then, you can explore the company&#8217;s technical analysis to know whether you should apply for the <strong>Asston Pharmaceuticals IPO<\/strong> or not.<\/p><p><strong>Asston Pharmaceuticals Limited Technicals<\/strong><\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Key Indicators<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/price-to-earnings-ratio-p-e-ratio\"><strong>PE Ratio (Price-to-Earnings)&nbsp;<\/strong><\/a><\/td><td>17.83<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/earnings-per-share-eps-formula\"><strong>EPS (Earnings Per Share)<\/strong><\/a><\/td><td>6.90<\/td><\/tr><tr><td><strong>RoNW<\/strong><\/td><td>40.36%<\/td><\/tr><tr><td><strong>ROCE<\/strong><\/td><td>51.25%<\/td><\/tr><tr><td><strong>ROE<\/strong><\/td><td>50.56%<\/td><\/tr><tr><td><strong>EBITDA Margin<\/strong><\/td><td>24.60%<\/td><\/tr><tr><td><strong>Price to Book Value<\/strong><\/td><td>12.07<\/td><\/tr><tr><td><strong>Market Capitalisation<\/strong><\/td><td>\u20b9104.70 cr.<\/td><\/tr><\/tbody><\/table><\/figure><p>The PE ratio of Asston Pharmaceuticals Limited shares is 17.83, and its Earnings Per Share (EPS) stands at 6.90. Thus, the <strong>Asston Pharmaceuticals IPO<\/strong> can potentially deliver gains on its tentative listing date, 16th July 2025.&nbsp;<\/p><p><strong><em>Note<\/em><\/strong><em>: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Asston Pharmaceuticals Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.&nbsp;<\/em><\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Indicators<\/strong><\/td><td><strong>Pre-IPO<\/strong><\/td><td><strong>Post-IPO<\/strong><\/td><\/tr><tr><td><strong>PE Ratio<\/strong><\/td><td>17.83<\/td><td>13.20<\/td><\/tr><tr><td><strong>EPS&nbsp;<\/strong><\/td><td>6.90<\/td><td>9.32<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Asston_Pharmaceuticals_Limited_Peer_Comparison\"><\/span><strong>Asston Pharmaceuticals Limited Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Company Name<\/strong><\/td><td><strong>Revenue (in cr.)<\/strong><\/td><td><strong>PE Ratio<\/strong><\/td><td><strong>Face Value (in Rs)<\/strong><\/td><td><strong>EPS&nbsp;<\/strong><\/td><td><strong>RoNW (in %)<\/strong><\/td><\/tr><tr><td><strong><a href=\"https:\/\/asstonpharmaceuticals.com\/\" rel=\"nofollow noopener\" target=\"_blank\">Asston Pharmaceuticals Limited<\/a><\/strong><\/td><td>25.61<\/td><td>17.83<\/td><td>10<\/td><td>6.90<\/td><td>40.36%<\/td><\/tr><tr><td><strong><a href=\"https:\/\/univest.in\/stocks\/shelter\/shelter-pharma-ltd-share-price-today\">Shelter Pharma Limited<\/a><\/strong><\/td><td>40.03<\/td><td>6.70<\/td><td>10<\/td><td>6.26<\/td><td>16.94%<\/td><\/tr><tr><td><strong><a href=\"https:\/\/univest.in\/stocks\/tll\/trident-lifeline-ltd-share-price-today\">Trident Lifeline Limited<\/a><\/strong><\/td><td>46.71<\/td><td>25.29<\/td><td>10<\/td><td>11.35<\/td><td>19.85%<\/td><\/tr><tr><td><strong><a href=\"https:\/\/univest.in\/stocks\/bafnaph\/bafna-pharmaceuticals-ltd-share-price-today\">BAFNA Pharmaceuticals Limited<\/a><\/strong><\/td><td>156.00<\/td><td>51.38<\/td><td>10<\/td><td>1.76<\/td><td>4.89%<\/td><\/tr><\/tbody><\/table><\/figure><p><em>For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!<\/em><\/p><p><strong><em>Also Read : <a href=\"https:\/\/univest.in\/blogs\/travel-food-services-ipo-gmp\">Travel Food Services IPO GMP: Day 1 IPO Live Updates<\/a><\/em><\/strong><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs_on_Asston_Pharmaceuticals_IPO\"><\/span><strong>FAQs on Asston Pharmaceuticals IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_Asston_Pharmaceuticals_IPO_GMP\"><\/span><strong>What is Asston Pharmaceuticals IPO GMP?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans. Currently, on 9th July 2025, <strong>Asston Pharmaceuticals IPO GMP<\/strong> (Grey Market Premium) stands at \u20b910 (8.13% up). This indicates that the estimated listing price could be \u20b9133 per share.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_issue_price_of_Asston_Pharmaceuticals_IPO\"><\/span><strong>What is the issue price of Asston Pharmaceuticals IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans. <strong>Asston Pharmaceuticals IPO<\/strong> price band has been set between \u20b9115 and \u20b9123 per share. Retail investors can apply for a minimum of 2 lots consisting of 2,000 shares worth \u20b92,46,000. Moreover, HNIs are required to bid for a minimum of 3 lots (3,000 shares) worth \u20b93,69,000.&nbsp;<br><\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Who_is_the_registrar_of_the_Asston_Pharmaceuticals_IPO\"><\/span><strong>Who is the registrar of the Asston Pharmaceuticals IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans. Maashitla Securities Private Limited is the registrar of the <strong>Asston Pharmaceuticals IPO,<\/strong> awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding the <strong>Asston Pharmaceuticals IPO<\/strong> allotment and refund, you can contact Maashitla Securities Private Limited at <a href=\"mailto:investor.ipo@maashitla.com\">investor.ipo@maashitla.com<\/a> or +91-11-45121795-96.<\/p><p><strong><em>Disclaimer<\/em><\/strong><em>: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Asston Pharmaceuticals IPO, download the Asston Pharmaceuticals IPO RHP and Asston Pharmaceuticals IPO DRHP. Conduct your own research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/zepto-ipo\">Zepto IPO Details: Everything You Should Know About<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/cff-fluid-control-ipo\">CFF Fluid Control IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/asston-pharmaceuticals-ipo-gmp\">Asston Pharmaceuticals IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/glen-industries-ipo-gmp\">GLEN Industries IPO GMP: Day 1 IPO Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/jsw-cement-ipo\">JSW Cement IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/flipkart-ipo\">Flipkart IPO Details: Everything You Should Know About<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/glen-industries-ipo\">GLEN Industries IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/smarten-power-systems-ipo-gmp\">Smarten Power Systems IPO GMP: Day 1 IPO Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/chemkart-india-ipo-gmp\">Chemkart India IPO GMP: Day 1 IPO Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/travel-food-services-ipo-gmp\">Travel Food Services IPO GMP: Day 1 IPO Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/nsdl-ipo\">NSDL IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><\/p>","protected":false},"excerpt":{"rendered":"<p>Asston Pharmaceuticals IPO GMP is \u20b910 as of 9th July 2025. It is a book building IPO of 22.41 lakh shares and entirely a fresh issue worth \u20b927.56 crore. The issue will be listed on BSE and SME on its tentative listing date, 16th July 2025. The price band for the Asston Pharmaceuticals IPO is<\/p>\n","protected":false},"author":23,"featured_media":43184,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[1374,1015,559],"class_list":["post-43170","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-asston-pharmaceuticals-ipo-gmp","tag-ipo","tag-ipo-information"],"metadata":{"_edit_lock":["1752060949:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["77"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"_wp_page_template":["default"],"rank_math_title":[" Asston Pharmaceuticals IPO GMP Day 1 | Check IPO Details"],"rank_math_description":[" Get Asston Pharmaceuticals IPO GMP status. Discover the IPO Price, Date, Subscription Status, Grey Market Premium GMP, Allotment, Listing Date, and Review. Read more!"],"rank_math_focus_keyword":["Asston Pharmaceuticals IPO"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"amazonS3_cache":["a:4:{s:69:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/07\/asston-image-2-08.jpg\";a:2:{s:2:\"id\";i:43185;s:11:\"source_type\";s:13:\"media-library\";}s:78:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/07\/asston-image-2-08-1024x536.jpg\";a:2:{s:2:\"id\";i:43185;s:11:\"source_type\";s:13:\"media-library\";}s:101:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/07\/09115023\/asston-image-2-08.jpg\";a:2:{s:2:\"id\";i:43185;s:11:\"source_type\";s:13:\"media-library\";}s:110:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/07\/09115023\/asston-image-2-08-1024x536.jpg\";a:2:{s:2:\"id\";i:43185;s:11:\"source_type\";s:13:\"media-library\";}}"],"_wp_old_slug":["asston-pharmaceuticals-ipo-gmp-2"],"_thumbnail_id":["43184"],"rank_math_analytic_object_id":["2212"],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/asston-pharmaceuticals-ipo"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/07\/09114913\/asston-image-1-08.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/43170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=43170"}],"version-history":[{"count":4,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/43170\/revisions"}],"predecessor-version":[{"id":43188,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/43170\/revisions\/43188"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/43184"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=43170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=43170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=43170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}